Charles River in HQ plasmid manufacturing deal with Fondazione Telethon

Charles River Laboratories International announced a High Quality, HQ, plasmid manufacturing collaboration with Fondazione Telethon. The rare disease organization will leverage Charles River’s market leading cell and gene contract development and manufacturing organization, CDMO, expertise in High Quality, HQ, plasmid DNA production, and Good Manufacturing Practice-, GMP, compliant plasmid DNA batches to manufacture HQ plasmid DNA for Fondazione Telethon’s lentivirus production that will be used in ex vivo cell and gene therapy. Fondazione Telethon is a non-profit organization and an internationally recognized biomedical research foundation focused on advancing biomedical research to cure rare genetic diseases. Founded in 1990, the Fondazione Telethon supports and finances scientific research of excellence for the study and treatment of genetic diseases. These efforts focus on developing effective therapies against these serious pathologies. A Robust Manufacturing Collaboration . “We are thrilled to work with Fondazione Telethon to produce HQ plasmid DNA for Fondazione Telethon’s lentivirus for ex vivo gene therapy. Charles River has had decades of success developing, producing, and reliably delivering plasmid DNA, which provides confidence customers are in safe hands.”